Holding in Company Archives - Advanced Medical Solutions

Holding(s) in Company

AdMedSol — Wed, 05 Jun 2024 08:42:59 +0000

RNS Number : 2087R

Advanced Medical Solutions Grp PLC

05 June 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0004536594

Issuer Name

ADVANCED MEDICAL SOLUTIONS GROUP PLC

UK or Non-UK Issuer

2. Reason for Notification

An acquisition or disposal of voting rights; An event changing the breakdown of voting rights – admission of shares 3^rd June 2024

3. Details of person subject to the notification obligation

Name

Octopus Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

England

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

03-Jun-2024

6. Date on which Issuer notified

04-Jun-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	12.980000	0.000000	12.980000	28243390
Position of previous notification (if applicable)	13.020000	0.000000	13.020000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0004536594		28243390		12.980000
Sub Total 8.A	28243390		12.980000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Octopus Capital Limited	Octopus Investments Limited	12.980000		12.980000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

04/06/2024

13. Place Of Completion

33 Holborn, London, EC1N 2HT

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUVSBRSRUNRRR

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Holding(s) in Company

Charlie Fife — Thu, 25 Apr 2024 15:41:15 +0000

25 April 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN
GB0004536594

Issuer Name

ADVANCED MEDICAL SOLUTIONS GROUP PLC

UK or Non-UK Issuer
UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name
Octopus Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)
England

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached
24-Apr-2024

6. Date on which Issuer notified
25-Apr-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	13.020000	0.000000	13.020000	28306252
Position of previous notification (if applicable)	12.990000	0.000000	12.990000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0004536594	0	28306252	0.000000	13.020000
Sub Total 8.A	28306252		13.020000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Octopus Capital Limited	Octopus Investments Limited	13.020000	0.000000	13.020000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion
25/04/2024

13. Place Of Completion
33 Holborn, London, EC1N 2HT

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Holding(s) in Company

Charlie Fife — Wed, 17 Apr 2024 15:30:57 +0000

17 April 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN
GB0004536594

Issuer Name

ADVANCED MEDICAL SOLUTIONS GROUP PLC

UK or Non-UK Issuer
UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name
Octopus Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)
England

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached
16-Apr-2024

6. Date on which Issuer notified
17-Apr-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	12.990000	0.000000	12.990000	28235366
Position of previous notification (if applicable)	13.010000	0.000000	13.010000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0004536594	0	28235366	0.000000	12.990000
Sub Total 8.A	28235366		12.990000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Octopus Capital Limited	Octopus Investments Limited	12.990000	0.000000	12.990000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion
17/04/2024

13. Place Of Completion
33 Holborn, London, EC1N 2HT

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Holding(s) in Company

Charlie Fife — Thu, 04 Apr 2024 15:17:08 +0000

04 April 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN
GB0004536594

Issuer Name

ADVANCED MEDICAL SOLUTIONS GROUP PLC

UK or Non-UK Issuer
UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name
Octopus Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)
England

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached
03-Apr-2024

6. Date on which Issuer notified
04-Apr-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	13.010000	0.000000	13.010000	28278589
Position of previous notification (if applicable)	12.060000	0.000000	12.060000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0004536594	0	28278589	0.000000	13.010000
Sub Total 8.A	28278589		13.010000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Octopus Capital Limited	Octopus Investments Limited	13.010000	0.000000	13.010000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion
04/04/2024

13. Place Of Completion
33 Holborn, London, EC1N 2HT

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Holding(s) in Company

AdMedSol — Mon, 25 Sep 2023 12:23:11 +0000

RNS Number : 5686N

Advanced Medical Solutions Grp PLC

25 September 2023

Name	City of registered office	Country of registered office
Investec Wealth & Investment Limited	London	UK
Rathbone Unit Trust Management	London	UK
Rathbones Investment Management International Limited	St Helier	Jersey

4. Details of the shareholder

Name	City of registered office	Country of registered office
Hero Nominees Limited	St Peter Port	Guernsey
Ferlim Nominees Limited	London	UK
NatWest Trustees Limited	London	UK
BNP Paribas Limited	London	UK
Rathbone Nominees Limited	London	UK

5. Date on which the threshold was crossed or reached

21-Sep-2023

6. Date on which Issuer notified

25-Sep-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 8.B 2)	Total of both in % (8.A 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	8.591500	0.000000	8.591500	18661710
Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0004536594		18661710		8.591500
Sub Total 8.A	18661710		8.591500%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Rathbones Group PLC	Rathbones Investment Management Limited	3.295000		3.295000%
Rathbones Group PLC	Rathbones Investment Management International Limited	0.006900		0.006900%
Rathbones Group PLC	Rathbone Unit Trust Management Limited	0.124300		0.124300%
Rathbones Group PLC	Investec Wealth & Investment Limited	5.165300		5.165300%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

None

12. Date of Completion

25-Sep-2023

13. Place Of Completion

Port of Liverpool Building, Liverpool L3 1NW

END

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Block listing Interim Review

AdMedSol — Thu, 14 Sep 2023 12:02:49 +0000

RNS Number : 5046M
Advanced Medical Solutions Grp PLC
14 September 2023

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

Name of applicant:		Advanced Medical Solutions Group plc
Name of scheme:		Block Scheme for: 1. Deferred Share Bonus Scheme 2. Company Share Option Plan 3. Unapproved Executive Share Option Scheme 4. Long Term Incentive Plan 5. Deferred Annual Bonus Scheme
Period of return:	From:	6 March 2023	To:	5 September 2023
Balance of unallotted securities under scheme(s) from previous return:		1. 152,679 2. 182,253 3. 586,952 4. 274,107 5. 246,341
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		1. Nil 2. Nil 3. Nil 4. Nil 5. Nil
Less: Number of securities issued/allotted under scheme(s) during period:		1. 85,483 2. 40,710 3. 40,766 4. 47,585 5. Nil
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		1. 67,196 2. 141,543 3. 546,186 4. 226,522 5. 246,341
Number and class of securities originally listed and the date of admission:		4,476,264 ordinary shares of 5p each on 6 September 2018

Name of contact:	Eddie Johnson
Telephone number of contact:	01606 545506

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

Standard form for notification of major holdings

AdMedSol — Mon, 19 Jun 2023 12:18:53 +0000

The post Standard form for notification of major holdings appeared first on Advanced Medical Solutions.

Holding(s) in Company

AdMedSol — Mon, 11 Oct 2021 15:35:11 +0000

RNS Number : 7031O

Advanced Medical Solutions Grp PLC

11 October 2021

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) ⁱ

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ⁱⁱ:			Advanced Medical Solutions Group plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) ⁱⁱⁱ:
3. Details of person subject to the notification obligation ^iv
Name			Octopus Investments Nominees Limited
City and country of registered office (if applicable)			33 Holborn, London, EC1N 2HT
4. Full name of shareholder(s) (if different from 3.) ^v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached ^vi:			08/10/2021
6. Date on which issuer notified (DD/MM/YYYY):			11/10/2021
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 8.B 2)		Total of both in % (8.A 8.B)	Total number of voting rights held in issuer (8.A 8.B) ^vii
Resulting situation on the date on which threshold was crossed or reached	12.06%	N/A		12.06%	26,013,930
Position of previous notification (if applicable)	11.04%	N/A		11.04%	23,768,708

TR-1: Standard form for notification of major holdings

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached ^viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ^ix					% of voting rights
		Direct (DTR5.1)		Indirect (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB0004536594				26,013,930					12.06%


SUBTOTAL 8. A		26,013,930					12.06%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date ^x	Exercise/ Conversion Period ^xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date ^x		Exercise/ Conversion Period ^xi		Physical or cash Settlement ^xii			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer ^xiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) ^xiv				X
Name ^xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Octopus Investments Nominees Ltd	12.06%





10. In case of proxy voting, please identify:
Name of the proxy holder		N/A
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information ^xvi

Place of completion	33 Holborn, London, EC1N 2HT
Date of completion	11/10/2021

END

HOLUAOSRAOURAAA

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Holding(s) in Company

AdMedSol — Fri, 30 Jul 2021 15:51:45 +0000

RNS Number : 1291H

Advanced Medical Solutions Grp PLC

30 July 2021

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached.

Advanced Medical Solutions Group PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation
Name	Aegon Asset Management UK PLC
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.)
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached :	28/07/2021
6. Date on which issuer notified (DD/MM/YYYY):	30/07/2021

7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 8.B 2)	Total of both in % (8.A 8.B)	Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached	2.91%	0.00%	2.91%	215,736,709
Position of previous notification (if applicable)	3.05%	0.00%	3.05%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
	Number of voting rights		% of voting rights
Class/type of shares ISIN code (if possible)	Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)	Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)	Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)	Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0004536594	3,292,182	2,975,488	1.53%	1.38%

SUBTOTAL 8. A	6,267,670		2.91%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument	Expiration date	Exercise/ Conversion Period	Number of voting rights that may be acquired if the instrument is exercised/converted.	% of voting rights

		SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument	Expiration date	Exercise/ Conversion Period	Physical or cash settlement	Number of voting rights	% of voting rights

			SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer				X
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)
Name	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial in-struments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Aegon Asset Management:- Aegon Asset Management UK PLC Aegon Asset Management UK ICVC Aegon Asset Management UK VCIC

10. In case of proxy voting, please identify:
Name of the proxy holder		Aegon Asset Management UK PLC
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information
Aegon Asset Management UK plc acquires holdings as agent and discretionary manager for underlying clients including: UCITS funds, other collective investment schemes and segregated, institutional clients. Exercise of voting rights is controlled by Aegon Asset Management UK plc.

Place of completion	Edinburgh, Scotland, United Kingdom
Date of completion	29 July 2021

END

HOLURVSRARUBOAR

The post Holding(s) in Company appeared first on Advanced Medical Solutions.

Holding(s) in Company

AdMedSol — Mon, 12 Apr 2021 15:15:40 +0000

RNS Number : 1888V

Advanced Medical Solutions Grp PLC

12 April 2021

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) ⁱ

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ⁱⁱ:			Advanced Medical Solutions Group PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) ⁱⁱⁱ:
3. Details of person subject to the notification obligation ^iv
Name			AXA Investment Managers S.A.
City and country of registered office (if applicable)			Paris – La Défense, France
4. Full name of shareholder(s) (if different from 3.) ^v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached ^vi:			08/04/2021
6. Date on which issuer notified (DD/MM/YYYY):			09/04/2021
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 8.B 2)		Total of both in % (8.A 8.B)	Total number of voting rights held in issuer (8.A 8.B) ^vii
Resulting situation on the date on which threshold was crossed or reached	4.94%	0.00%		4.94%	10,645,216
Position of previous notification (if applicable)	9.57%	0.00%		9.57%	20,878,747

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached ^viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ^ix					% of voting rights
		Direct (DTR5.1)		Indirect (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
5p ordinary GB0004536594				10,645,216					4.94%


SUBTOTAL 8. A		10,645,216					4.94%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date ^x	Exercise/ Conversion Period ^xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights



			SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date ^x		Exercise/ Conversion Period ^xi		Physical or cash Settlement ^xii			Number of voting rights	% of voting rights



					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer ^xiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) ^xiv				X
Name ^xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
AXA Investment Managers S.A.	–	–	–
AXA Framlington Group Ltd.	–	–	–
AXA Investment Managers UK Limited	4.94%		4.94%



10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information ^xvi

Place of completion	Paris – La Défense, France
Date of completion	09/04/2021

END

HOLUUASRAOUSAAR

The post Holding(s) in Company appeared first on Advanced Medical Solutions.